Prestige Consumer Healthcare
PBH
#3965
Rank
NZ$5.24 B
Marketcap
NZ$109.12
Share price
1.16%
Change (1 day)
-29.47%
Change (1 year)

Earnings for Prestige Consumer Healthcare (PBH)

Earnings in 2025 (TTM): NZ$0.49 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's current earnings are NZ$1.11 Billion. In 2024 the company made an earning of NZ$0.45 Billion, an increase over its 2023 earnings that were of -NZ$0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prestige Consumer Healthcare from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.49 B7.66%
2024 NZ$0.45 B-405.61%
2023 -NZ$0.15 Billion-134.07%
2022 NZ$0.44 B10.21%
2021 NZ$0.39 B12.88%
2020 NZ$0.35 B-657.8%
2019 -NZ$63.41 Million-143.45%
2018 NZ$0.14 B-50.46%
2017 NZ$0.29 B52.98%
2016 NZ$0.19 B-31.39%
2015 NZ$0.28 B45.68%
2014 NZ$0.19 B10.59%
2013 NZ$0.17 B38.24%
2012 NZ$0.12 B8.79%
2011 NZ$0.11 B55.18%
2010 NZ$74.64 M-123.77%
2009 -NZ$0.32 Billion-446.47%
2008 NZ$90.63 M8.03%
2007 NZ$83.9 M-3.71%
2006 NZ$87.13 M42.33%
2005 NZ$61.21 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$53.47 B 11,266.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$35.45 B 7,437.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$26.99 B 5,637.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$19.56 B 4,058.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$13.43 B 2,755.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$1.62 B 245.94%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$9.90 B 2,004.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$15.38 B 3,170.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-NZ$2.3 Billion-588.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$72.17 M-84.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel